These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6423547)

  • 1. The combined action of azlocillin and sisomicin in a model simulating the in vivo serum kinetics.
    Haller I
    Infection; 1983; 11 Suppl 2():S81-2. PubMed ID: 6423547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined action of decreasing concentrations of azlocillin and sisomicin on Pseudomonas aeruginosa as assessed in a dynamic in vitro model.
    Haller I
    Infection; 1982; 10 Suppl 3():S229-33. PubMed ID: 6818155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
    Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
    Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa.
    Eykyn SJ
    J Antimicrob Chemother; 1982 May; 9(5):395-403. PubMed ID: 6807951
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data.
    Haag R
    Chemotherapy; 1984; 30(4):227-36. PubMed ID: 6430654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies with azlocillin, mezlocillin, penicillin-g-potassium and sisomicin on tolerance in the cornea and the kinetics of inhibiting concentrations in the cornea and aqueous humor in rabbits].
    Gauri KK; Finck J; Claussen B; Schassan HH; Fedder J; Weuta H
    Infection; 1982; 10 Suppl 3():S221-6. PubMed ID: 6218119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
    Davidson S; Yellin EO; Shaked I; Rubinstein E
    Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
    Vestin L; Burman LA; Holm S; Sellers J
    Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of serious Pseudomonas infections with azlocillin.
    Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
    J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transperitoneal resorption of oxacillin, azlocillin and sisomicin in continuous ambulatory peritoneal dialysis in patients with and without peritonitis].
    Thomae U; Boos W; Adam D
    Med Welt; 1981 Sep; 32(37):1365-7. PubMed ID: 7300642
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and clinical aspects of azlocillin in paediatrics.
    Heimann G
    J Antimicrob Chemother; 1983 May; 11 Suppl B():127-35. PubMed ID: 6619022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of mezlocillin and endotracheally administered sisomicin with or without parenteral sisomicin in the treatment of Gram-negative bronchopneumonia.
    Sculier JP; Coppens L; Klastersky J
    J Antimicrob Chemother; 1982 Jan; 9(1):63-8. PubMed ID: 6460730
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.